During a panel at HFMA’s annual conference, two healthcare credit analysts said the industry is already fracturing into winners and losers. And with 2030 bringing a perfect storm of demographic pressure, reimbursement cuts and AI disruption, they think window for bold action is closing fast. The post ‘2030 Scares Me to Death’: Credit Analysts’ Urgent Warning for Healthcare CFOs appeared first on MedCity News .
The FDA has approved the sunscreen chemical bemotrizinol, a UV light filter that has been available in Europe, Asia, and Australia for more than 20 years. Health advocates and skin care industry groups alike are hopeful it can restore faith in sunscreen.
Parabilis Medicines is developing a new type of peptide drug capable of hitting elusive disease targets inside cells. Cancer is the biotech’s initial focus, and the IPO cash will support a lead program zolucatetide, which is in development for a rare type of tumor with limited treatment options. The post Parabilis Medicines’ Quest to Drug the Undruggable Picks Up $745M From Upsized IPO appeared first on MedCity News .
The next evolution of patient experience will not be defined by more digital touchpoints. It will be defined by giving nurses and care teams the capacity to be fully present. The post Restoring the Patient-Clinician Relationship to the Center of Care appeared first on MedCity News .
Prevention requires more than faster detection. Organizations need payment programs with end-to-end visibility and controls that intervene before losses occur. The post From Detection to Defense: Building Fraud-Resilient Healthcare Payment Systems appeared first on MedCity News .
[Sponsored] Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs. The post The Healthcare Payments Industry Has a Perception Problem appeared first on MedCity News .
Healthcare needs systems that work for providers, for health plans, and most importantly, for patients. And that starts with designing not just for technology, but for the people who depend on it, people who need to trust it will work when it matters most. The post Healthcare IT Isn’t Broken — But How We Design It Might Be appeared first on MedCity News .
[Sponsored] Our new report will focus on how people who work for payers are thinking about AI and cybersecurity needs to protect sensitive healthcare data. The post Take Part in Our Survey on Healthcare AI and Security appeared first on MedCity News .
One of California’s largest healthcare unions is sponsoring two initiatives that would regulate community clinics and cap executive and managerial pay at hospitals and physician groups. In the most recent eruption of a long-standing feud, the measures have drawn fierce opposition from a wide swath of the medical industry.
Measles has been spreading in Utah for nearly a year, straining hospitals, schools, and parents. The state’s outbreak provides a glimpse into a new era in America’s health, in which vaccine-preventable diseases become common again.
CMS Administrator Dr. Mehmet Oz outlined the agency’s strategy for making healthcare more affordable during a Tuesday address at the HFMA Annual Conference, touching on everything from Medicare fraud to drug pricing to nutrition. The post The 5 Areas Where Dr. Oz Says CMS Can Make Healthcare More Affordable appeared first on MedCity News .
GSK’s Nuvalent acquisition brings two lead programs, each addressing different targets for non-small cell lung cancer. The Nuvalent lung cancer drugs are under FDA review and if they’re approved, GSK plans to launch both this year. The post GSK Gets a Pair of Near-Commercial Lung Cancer Drugs via $10.6B Nuvalent Acquisition appeared first on MedCity News .